C22H22N6O3
Neat
418.46
Futibatinib; 1448169-71-8; TAS-120; Lytgobi; 4B93MGE4AL; TAS 120; 1-[(3S)-3-[4-amino-3-[2-(3, 5-dimethoxyphenyl)ethynyl]pyrazolo[3, 4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one; 2-Propen-1-one, 1-((3S)-3-(4-amino-3-(2-(3, 5-dimethoxyphenyl)ethynyl)-1H-pyrazolo(3, 4-d)pyrimidin-1-yl)-1-pyrrolidinyl)-; 1-[(3S)-3-{4-amino-3-[(3, 5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3, 4-d]pyrimidin-1-yl}pyrrolidin-1-yl]prop-2-en-1-one; futibatinibum; 1-((3S)-3-(4-Amino-3-((3, 5-dimethoxyphenyl)ethynyl)-1H-pyrazolo(3, 4-d)pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one; 1-((3S)-3-(4-amino-3-(2-(3, 5-dimethoxyphenyl)ethynyl)pyrazolo(3, 4-d)pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one; RefChem:57740; 1-((3S)-3-(4-amino-3-(2-(3, 5-dimethoxyphenyl)ethynyl)-1H-pyrazolo(3, 4-d)pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one; Fgfr-in-1; Futibatinib [USAN]; TAS120; UNII-4B93MGE4AL; (S)-1-(3-(4-amino-3-((3, 5-dimethoxyphenyl)ethynyl)-1H-pyrazolo[3 and 4-d]pyrimidin-1-yl)pyrrolidin-1-yl)prop-2-en-1-one; TAS 120 [WHO-DD]
1-[(3S)-3-[4-amino-3-[2-(3, 5-dimethoxyphenyl)ethynyl]pyrazolo[3 and 4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one
InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1